TY - JOUR
T1 - The outcome of ulcerative colitis patients undergoing pouch surgery is determined by pre-surgical factors
AU - Yanai, H.
AU - Ben-Shachar, S.
AU - Mlynarsky, L.
AU - Godny, L.
AU - Leshno, M.
AU - Tulchinsky, H.
AU - Dotan, I.
N1 - Publisher Copyright:
© 2017 John Wiley & Sons Ltd
PY - 2017/9
Y1 - 2017/9
N2 - Background: Pouch surgery, a common intervention for ulcerative colitis (UC) complications, is often associated with the development of pouchitis. Aim: To identify predictors of pouch outcome in a cohort of patients with UC. Methods: We conducted a retrospective unmatched case-cohort study in a tertiary IBD referral centre. Adult patients with UC were classified into the worst phenotype throughout follow-up: normal pouch, a form of chronic pouchitis (either chronic pouchitis or Crohn's like disease of pouch [CLDP]), or episodic recurrent acute pouchitis (RAP). Risk factors for pouchitis (chronic forms) were detected using statistical models. Results: Two hundred and fifty-three pouch patients were followed up for 13.1±7.3 years. Only 71 patients (28.1%) maintained a favourable outcome of a sustained normal pouch. These patients were older at UC diagnosis (27.8±12.5 vs 23.0±11.4 years), had longer UC duration until surgery (13.4±9.5 vs 8.2±7.9 years), and had higher rates of referral to surgery due to nonrefractory (dysplasia/neoplasia) complications (42.3% vs 16.2%) compared with pouchitis patients. Median survival for sustained normal pouch was 10.8 years (95% CI 8.9-12.7 years), and it was longer in the nonrefractory group (20.3 vs 9.4 years for the refractory group, HR=2.37, 95% CI 1.25-3.52, P=.004). Conclusions: Most patients with UC undergoing pouch surgery will develop pouchitis. Patients operated for nonrefractory indications have a more favourable outcome. These results may contribute to pre- and post-surgical decision-making. The findings imply that the processes determining UC severity may be similar to that causing pouchitis.
AB - Background: Pouch surgery, a common intervention for ulcerative colitis (UC) complications, is often associated with the development of pouchitis. Aim: To identify predictors of pouch outcome in a cohort of patients with UC. Methods: We conducted a retrospective unmatched case-cohort study in a tertiary IBD referral centre. Adult patients with UC were classified into the worst phenotype throughout follow-up: normal pouch, a form of chronic pouchitis (either chronic pouchitis or Crohn's like disease of pouch [CLDP]), or episodic recurrent acute pouchitis (RAP). Risk factors for pouchitis (chronic forms) were detected using statistical models. Results: Two hundred and fifty-three pouch patients were followed up for 13.1±7.3 years. Only 71 patients (28.1%) maintained a favourable outcome of a sustained normal pouch. These patients were older at UC diagnosis (27.8±12.5 vs 23.0±11.4 years), had longer UC duration until surgery (13.4±9.5 vs 8.2±7.9 years), and had higher rates of referral to surgery due to nonrefractory (dysplasia/neoplasia) complications (42.3% vs 16.2%) compared with pouchitis patients. Median survival for sustained normal pouch was 10.8 years (95% CI 8.9-12.7 years), and it was longer in the nonrefractory group (20.3 vs 9.4 years for the refractory group, HR=2.37, 95% CI 1.25-3.52, P=.004). Conclusions: Most patients with UC undergoing pouch surgery will develop pouchitis. Patients operated for nonrefractory indications have a more favourable outcome. These results may contribute to pre- and post-surgical decision-making. The findings imply that the processes determining UC severity may be similar to that causing pouchitis.
UR - http://www.scopus.com/inward/record.url?scp=85021713290&partnerID=8YFLogxK
U2 - 10.1111/apt.14205
DO - 10.1111/apt.14205
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85021713290
SN - 0269-2813
VL - 46
SP - 508
EP - 515
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 5
ER -